From muddying the waters on vaccine policy to espousing MAHA, Kennedy’s first month in office offers a glimpse into the next four years of public health.

Shaquille O’Neal could dominate a basketball game on his own, but just like he sometimes needed Kobe Bryant, it turns out he also occasionally needs a cavalry to help him treat people’s pain with Icy ...

In the complex pharmaceutical market, achieving high levels of brand memorability directly influences patient choices and adherence, making it a critical focus for marketing strategies.

By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions ...

Following a recent spate of spots tackling gun violence from organizations including Project Unloaded and Sandy Hook Promise, two new PSAs highlighting the importance ...

John Wren, the chairman and chief executive of Omnicom, said: “We are very pleased to reach this important milestone. The strong support of our stockholders confirms the compelling value proposition ...

When the FDA announced in January, before President Joe Biden’s term ended, that it would ban a dye called red dye No. 3 in food and ingested drugs, the federal agency cited just one 1987 study on ...

Data segments leave a lot to be desired, and the solutions put in place to fix them are complicated. Campaign talks to ...

“Breaking news: The Trump administration just announced that Medicare will stop covering telehealth starting April 1. … We need to stand up to these Medicare cuts.” — Rep. Ro. Khanna (D-Calif.), in a ...

California’s Medicaid program has borrowed $3.4 billion from the state’s general fund to cover ballooning health expenses for 15 million residents with low incomes and disabilities.

When patients walked into Planned Parenthood clinics, a consumer data company sold their precise locations to anti-abortion groups for targeted ads. When patients picked up prescriptions for ...

The mRNA technology is under study at the NIH for prevention and treatment of infectious diseases, including flu and AIDS, and also cancer.